Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors (Q40609630)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2000
edit
Language Label Description Also known as
English
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
scientific article published on December 2000

    Statements

    Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors (English)
    1 December 2000
    1707-1712

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit